Genome-scale CRISPR pooled screens

Analytical Biochemistry

Volumn 532, Issue , 2017, Pages 95-99

  Sanjana, Neville E ^a,b  

^a NEW YORK GENOME CENTER   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Cancer; Cas9; CRISPR; Genetic screens; Genome engineering; Noncoding

Indexed keywords

ARTICLE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GAIN OF FUNCTION MUTATION; GENOME; LOSS OF FUNCTION MUTATION; PRIORITY JOURNAL; CRISPR CAS SYSTEM; GENE EDITING; GENE TARGETING; GENETIC ENGINEERING; GENETICS; HUMAN; HUMAN GENOME; PROCEDURES;

GUIDE RNA;

CRISPR-CAS SYSTEMS; GENE EDITING; GENE TARGETING; GENETIC ENGINEERING; GENOME, HUMAN; HUMANS; RNA, GUIDE;

EID: 85006341892     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2016.05.014     Document Type: Article

References (36)

1. Echeverri, C.J., Beachy, P.A., Baum, B., Boutros, M., Buchholz, F., Chanda, S.K., et al. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat. Methods 3 (2006), 777–779.
2. Singh, S., Wu, X., Ljosa, V., Bray, M.-A., Piccioni, F., Root, D.E., et al. Morphological profiles of RNAi-induced gene knockdown are highly reproducible but dominated by seed effects. PLoS One, 10(7), 2015, e0131370.
3. Shalem, O., Sanjana, N.E., Hartenian, E., Shi, X., Scott, D.A., Mikkelsen, T.S., et al. Genome-scale CRISPR–Cas9 knockout screening in human cells. Science 343 (2014), 84–87.
4. Wang, T., Wei, J.J., Sabatini, D.M., Lander, E.S., Genetic screens in human cells using the CRISPR–Cas9 system. Science 343 (2014), 80–84.
5. Mojica, F.J.M., Díez-Villaseñor, C., García-Martínez, J., Soria, E., Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol. 60 (2005), 174–182.
6. Pourcel, C., Salvignol, G., Vergnaud, G., CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiol. Read. UK 151 (2005), 653–663.
7. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
8. Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., et al. RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826.
9. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339 (2013), 819–823.
10. Jinek, M.M., Chylinski, K.K., Fonfara, I., Hauer, M.M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
11. Hsu, P.D., Lander, E.S., Zhang, F., Development and applications of CRISPR–Cas9 for genome engineering. Cell 157 (2014), 1262–1278.
12. Koike-Yusa, H., Li, Y., Tan, E.-P., Velasco-Herrera, M.C., Yusa, K., Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32 (2014), 267–273.
13. Sanjana, N.E., Shalem, O., Zhang, F., Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11 (2014), 783–784.
14. Shi, J., Wang, E., Milazzo, J.P., Wang, Z., Kinney, J.B., Vakoc, C.R., Discovery of cancer drug targets by CRISPR–Cas9 screening of protein domains. Nat. Biotechnol. 33 (2015), 661–667.
15. Ma, H., Dang, Y., Wu, Y., Jia, G., Anaya, E., Zhang, J., et al. A CRISPR-based screen identifies genes essential for West-Nile-Virus-induced cell death. Cell Rep. 12 (2015), 673–683.
16. Birsoy, K., Wang, T., Chen, W.W., Freinkman, E., Abu-Remaileh, M., Sabatini, D.M., An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162 (2015), 540–551.
17. Wang, T., Birsoy, K., Hughes, N.W., Krupczak, K.M., Post, Y., Wei, J.J., et al. Identification and characterization of essential genes in the human genome. Science 350 (2015), 1096–1101.
18. Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K.R., MacLeod, G., et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163 (2015), 1515–1526.
19. Toledo, C.M., Ding, Y., Hoellerbauer, P., Davis, R.J., Basom, R., Girard, E.J., et al. Genome-wide CRISPR–Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in glioblastoma stem-like cells. Cell Rep. 13 (2015), 2425–2439.
20. Chen, S., Sanjana, N.E., Zheng, K., Shalem, O., Lee, K., Shi, X., et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160 (2015), 1246–1260.
21. Parnas, O., Jovanovic, M., Eisenhaure, T.M., Herbst, R.H., Dixit, A., Ye, C.J., et al. A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks. Cell 162 (2015), 675–686.
22. Schmid-Burgk, J.L., Chauhan, D., Schmidt, T., Ebert, T.S., Reinhardt, J., Endl, E., et al. A genome-wide CRISPR screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J. Biol. Chem. 291 (2016), 103–109.
23. Konermann, S., Brigham, M.D., Trevino, A.E., Joung, J., Abudayyeh, O.O., Barcena, C., et al. Genome-scale transcriptional activation by an engineered CRISPR–Cas9 complex. Nature 517 (2015), 583–588.
24. Gilbert, L.A., Horlbeck, M.A., Adamson, B., Villalta, J.E., Chen, Y., Whitehead, E.H., et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159 (2014), 647–661.
25. Das Thakur, M., Stuart, D.D., The evolution of melanoma resistance reveals therapeutic opportunities. Cancer Res. 73 (2013), 6106–6110.
26. Huang, S., Hölzel, M., Knijnenburg, T., Schlicker, A., Roepman, P., McDermott, U., et al. MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling. Cell 151 (2012), 937–950.
27. Whittaker, S.R., Theurillat, J.-P., Van Allen, E., Wagle, N., Hsiao, J., Cowley, G.S., et al. A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. Cancer Discov. 3 (2013), 350–362.
28. Evers, B., Jastrzebski, K., Heijmans, J.P.M., Grernrum, W., Beijersbergen, R.L., Bernards, R., CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes. Nat. Biotechnol., 2016, 10.1038/nbt.3536.
29. Luo, B., Cheung, H.W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., et al. Highly parallel identification of essential genes in cancer cells. Proc. Natl. Acad. Sci. USA. 105 (2008), 20380–20385.
30. Marcotte, R., Brown, K.R., Suarez, F., Sayad, A., Karamboulas, K., Krzyzanowski, P.M., et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov. 2 (2012), 172–189.
31. GTEx Consortium, The Genotype–Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science 348 (2015), 648–660.
32. Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445 (2007), 168–176.
33. Thakore, P.I., D'Ippolito, A.M., Song, L., Safi, A., Shivakumar, N.K., Kabadi, A.M., et al. Highly specific epigenome editing by CRISPR–Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12 (2015), 1143–1149.
34. Kearns, N.A., Pham, H., Tabak, B., Genga, R.M., Silverstein, N.J., Garber, M., et al. Functional annotation of native enhancers with a Cas9–histone demethylase fusion. Nat. Methods 12 (2015), 401–403.
35. Canver, M.C., Smith, E.C., Sher, F., Pinello, L., Sanjana, N.E., Shalem, O., et al. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature 527 (2015), 192–197.
36. Findlay, G.M., Boyle, E.A., Hause, R.J., Klein, J.C., Shendure, J., Saturation editing of genomic regions by multiplex homology-directed repair. Nature 513 (2014), 120–123.